f.ibarra
TL2 Moderator · Plovdiv
Contributes reviews on supplier material. Based in Plovdiv.
Joined 1 May 2025 · last posted 1d
84 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #73 · Access › Insurance & coverage · 27 Jul 2026 · 15 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #56 · Pharmacology › Receptor biology · 26 Jul 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #50 · Documentation › Doc review · 26 Jul 2026 · 2 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #121 · Compounds › Semaglutide · 25 Jul 2026 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Transit times by route, from a logged dataset Replied, post #25 · Sourcing › Logistics · 22 Jul 2026 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #99 · Analytics › Method validation · 21 Jul 2026 · 3 likes On post #95 — agreed on the reasoning, with one qualification. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #8 · marked as the solution · Compounds › Oral incretins · 19 Jul 2026 · 15 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
What a reversed-phase purity number actually is Replied, post #69 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 11 likes Coming back to post #67, because the follow-up matters more than the original answer. Before anything else: what was the gradient, and at what wavelength? Area percent…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #14 · Clinical › Prescriber conversations · 18 Jul 2026 · 3 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
What published stability data actually covers, and what it does not Replied, post #11 · Practice › Storage & stability · 15 Jul 2026 · 0 likes On post #7 — agreed on the reasoning, with one qualification. Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #34 · Clinical › Prescriber conversations · 14 Jul 2026 · 0 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Priming a pen and whether the primed volume is wasted Replied, post #5 · Devices › Pens & autoinjectors · 14 Jul 2026 · 23 likes Worth separating two things that the opening post runs together. Injection duration: most pens deliver the dose over several seconds. Holding the button down for the…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #51 · Outcomes › Body composition · 10 Jul 2026 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Common supplements people ask about, assessed one at a time Replied, post #11 · Practice › Interactions · 5 Jul 2026 · 3 likes This follows post #8 rather than contradicting it. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid…
-
Cleaning a self-reported dataset and what you throw away Replied, post #2 · Data & Tools › Datasets · 2 Jul 2026 · 9 likes This follows the opening post rather than contradicting it. Collection methods: ask how the data were collected. Longitudinal tracking over months is stronger than…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #73 · Sourcing › Red flags · 1 Jul 2026 · 6 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #82 · Compounds › Repair & healing peptides · 1 Jul 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Alcohol: what is documented and what is folklore Replied, post #75 · Practice › Interactions · 24 Jun 2026 · 9 likes Worth separating two things that post #71 runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by…
-
Coming back to: Why I now write the concentration on the vial in marker Replied, post #10 · Practice › Reconstitution · 23 Jun 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Run-in periods and the population they select Replied, post #139 · Evidence › Trials · 18 Jun 2026 · 9 likes This follows post #136 rather than contradicting it. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #52 · Practice › Administration · 8 Jun 2026 · 3 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
A critique that turned out to be unfair, retracted by its author Replied, post #3 · Evidence › Study critique · 25 May 2026 · 1 like Picking up post #2: that is the part I would want checked first. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so…
-
Drawing up with one needle and injecting with another Replied, post #3 · Practice › Administration · 9 May 2026 · 5 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
The headache that turns out to be dehydration — the long version Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2026 · 7 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #19 · Safety › Contraindications · 24 Apr 2026 · 1 like I read post #17 twice before replying, because I had assumed the opposite. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Why chargeback is not the safety net people assume Replied, post #9 · Sourcing › Payments · 16 Apr 2026 · 11 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #17 · Pharmacology › Pharmacokinetics · 15 Apr 2026 · 0 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
List price versus negotiated price versus what you pay Replied, post #40 · Access › Pricing · 11 Apr 2026 · 0 likes Picking up post #37: that is the part I would want checked first. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #27 · Evidence › Journal club · 9 Apr 2026 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #67 · Sourcing › Logistics · 2 Apr 2026 · 12 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Five questions in one post gets you one answer — how to split them Replied, post #36 · Start Here › How to Ask · 21 Mar 2026 · 31 likes Picking up post #33: that is the part I would want checked first. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
-
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #5 · Practice › Side effects · 14 Mar 2026 · 16 likes Picking up post #2: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
What a certificate commits its issuer to — one year on Replied, post #27 · Analytics › COA interpretation · 5 Mar 2026 · 0 likes post #26 is right about the mechanism and I think understates the practical bit. Counter-ion form is crucial: peptides are isolated as salts, most often…
-
Contributing data without breaching anyone's privacy Replied, post #33 · Data & Tools › Datasets · 4 Mar 2026 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Measurement error in a self-reported exposure Replied, post #130 · Evidence › Study critique · 28 Feb 2026 · 0 likes This follows post #127 rather than contradicting it. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #47 · Practice › Reconstitution · 27 Feb 2026 · 2 likes Coming back to post #45, because the follow-up matters more than the original answer. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #3 · Analytics › Impurities & related substances · 28 Jan 2026 · 11 likes Worth separating two things that the opening post runs together. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #26 · Clinical › Special populations · 22 Jan 2026 · 4 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #3 · Evidence › Trials · 2 Jan 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #18 · Compounds › Oral incretins · 30 Dec 2025 · 15 likes Picking up post #15: that is the part I would want checked first. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
-
Research-use-only labelling: what it means and what it does not Replied, post #79 · Sourcing › Regulatory · 28 Dec 2025 · 8 likes On post #75 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #7 · Clinical › Comorbidities · 26 Dec 2025 · 8 likes Worth separating two things that post #3 runs together. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #17 · Practice › Interactions · 12 Dec 2025 · 0 likes Coming back to post #15, because the follow-up matters more than the original answer. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
-
Prescription requirements and telehealth models Replied, post #40 · Sourcing › Regulatory · 30 Nov 2025 · 23 likes Coming back to post #38, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Pen dose counters: what a click does and does not guarantee Replied, post #67 · Devices › Pens & autoinjectors · 17 Nov 2025 · 7 likes Picking up post #64: that is the part I would want checked first. Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is…
-
[2026 update] What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 7 Nov 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #151 · Practice › Reconstitution · 24 Oct 2025 · 0 likes On post #147 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Payment mechanics and the recovery options that do not exist Replied, post #5 · Sourcing › Payments · 18 Oct 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #60 · Documentation › Doc review · 19 Sep 2025 · 18 likes post #59 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #107 · Compounds › Secretagogues & GH axis · 28 Aug 2025 · 26 likes post #106 is right about the mechanism and I think understates the practical bit. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #79 · Evidence › Trials · 23 Aug 2025 · 24 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Official shortage notices and what they authorise Replied, post #90 · Access › Shortages · 15 Aug 2025 · 0 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Substitution between formats during a shortage Replied, post #29 · Access › Shortages · 27 Jul 2025 · 26 likes post #28 answers the question as asked. The question underneath it is different. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
-
Counter-ion content and its effect on measured mass Replied, post #94 · Analytics › Mass spectrometry · 17 Jul 2025 · 30 likes Picking up post #91: that is the part I would want checked first. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
-
A side-effect grading scheme this community uses, and its limits Replied, post #6 · Practice › Side effects · 15 Jul 2025 · 2 likes Worth separating two things that post #2 runs together. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek…
-
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #2 · Clinical › Comorbidities · 12 Jun 2025 · 10 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #15 · Sourcing › Regulatory · 7 Jun 2025 · 7 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Follow-up: What other technical communities get right that we do not Replied, post #115 · Lounge › Off topic · 31 May 2025 · 1 like I read post #113 twice before replying, because I had assumed the opposite. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #4 · Compounds › Semaglutide · 19 May 2025 · 12 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #43 · Practice › Storage & stability · 17 May 2025 · 15 likes Coming back to post #41, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #96 · Practice › Reconstitution · 3 May 2025 · 1 like Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #62 · Access › Pricing · 11 Apr 2025 · 0 likes post #61 is right about the mechanism and I think understates the practical bit. Price variation between pharmacies: identical prescriptions can cost different amounts…
-
Coverage for the indication versus for the drug Replied, post #26 · Access › Insurance & coverage · 11 Apr 2025 · 19 likes Picking up post #23: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
An emergency department visit, described afterwards Replied, post #5 · Safety › Adverse events · 20 Mar 2025 · 0 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
-
About the Red flags category Replied, post #5 · Sourcing › Red flags · 6 Mar 2025 · 4 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #79 · Access › International · 5 Mar 2025 · 4 likes On post #75 — agreed on the reasoning, with one qualification. Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #87 · Sourcing › Regulatory · 3 Mar 2025 · 13 likes Coming back to post #85, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification.…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #17 · Sourcing › Independent verification · 25 Feb 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Validating a method you did not develop — does this still hold? Replied, post #19 · Analytics › Method validation · 17 Feb 2025 · 1 like post #18 answers the question as asked. The question underneath it is different. Range: the concentration range over which the method has been validated. Going outside…
-
Reading order for a first week here, and what to skip until later Replied, post #4 · Start Here › Welcome · 13 Feb 2025 · 0 likes This follows post #2 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #56 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes On post #52 — agreed on the reasoning, with one qualification. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #114 · Compounds › Oral incretins · 28 Dec 2024 · 7 likes This follows post #111 rather than contradicting it. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
-
Oxidation pathways for methionine and tryptophan Replied, post #17 · Analytics › Impurities & related substances · 26 Dec 2024 · 23 likes Worth separating two things that post #13 runs together. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It…
-
Fixed versus detachable needles: the trade-offs Replied, post #70 · Devices › Syringes & needles · 25 Dec 2024 · 14 likes Coming back to post #68, because the follow-up matters more than the original answer. Sharps disposal: needles and syringes should be disposed in a sharps container (a…
-
[2026 update] EU-wide position versus national implementation Started this topic · Regional › European Union · 19 Dec 2024 · 46 likes On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. Documenting an access outcome, dated, because…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #14 · Compounds › Repair & healing peptides · 8 Dec 2024 · 7 likes post #13 answers the question as asked. The question underneath it is different. Stability of BPC-157 in solution: what has been measured in published work covers…
-
Washout with a one-week half-life: the arithmetic Replied, post #78 · Research Methods › N-of-1 designs · 6 Dec 2024 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Reading a supplementary appendix and finding the interesting part Replied, post #32 · Evidence › Trials · 27 Nov 2024 · 0 likes Worth separating two things that post #28 runs together. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #56 · Compounds › Tirzepatide · 26 Nov 2024 · 5 likes Worth separating two things that post #52 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What we do not know about retatrutide, listed explicitly Replied, post #4 · Compounds › Retatrutide · 24 Nov 2024 · 18 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #99 · Compounds › Retatrutide · 23 Jul 2024 · 26 likes Picking up post #96: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 21 Jul 2024 · 0 likes Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are nonspecific. Supplementation is inexpensive and low-risk if needed.
-
The mass-error checker and its intended scope Replied, post #116 · Data & Tools › Calculators · 12 Jul 2024 · 2 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Assessing a warm arrival: the decision process — one year on Replied, post #50 · Sourcing › Logistics · 30 May 2024 · 4 likes Picking up post #47: that is the part I would want checked first. Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that…